BIO-RAD laboratories:1110109 [16-023212]
Ended Awarded
- Contract number
- HHSN26100003
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,000
Award facts
- Contract value 100% obligated
- $22,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
Bio-Rad Laboratories, Inc.'s Life Science Group Division received a $22,000 firm fixed-price Blanket Purchase Agreement (BPA) call order from the National Cancer Institute (NCI) on March 31, 2016, with an ultimate completion date of April 30, 2016. This contract was awarded without a small business set-aside designation. The work is to be performed at the NCI facility in Bethesda, Maryland. As a BPA call order, this award represents a specific procurement action executed under an existing agreement that provides Bio-Rad with a streamlined mechanism for delivering laboratory equipment, reagents, or consumables to support the Institute's cancer research initiatives.
Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics, headquartered in Hercules, California, and specializes in providing advanced scientific instrumentation including polymerase chain reaction systems, thermal cyclers, droplet digital PCR instruments, gel imaging systems, and specialized reagents to federal agencies. The company maintains a significant $10 million BPA with the National Institutes of Health Office of Logistics and Acquisition Operations through December 31, 2025, which has enabled numerous call orders across NIH institutes and related agencies for critical research instrumentation and biological materials. This NCI award exemplifies Bio-Rad's established role as a preferred supplier of sophisticated laboratory technologies supporting federal biomedical research and diagnostic capabilities.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on March 31, 2016.
How much is contract HHSN26100003 worth?
The government has obligated $22,000 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a BPA call under HHSN263201500172B, a blanket purchase agreement.
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award